Propranolol in the treatment of infantile haemangiomas: Lessons from the European Propranolol in the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey

E. Wedgeworth, M. Glover, A. D. Irvine, I. Neri, E. Baselga, T. H. Clayton, P. E. Beattie, J. V. Bjerre, N. P. Burrows, R. Foelster-Holst, L. Hedelund, A. Hernandez-Martin, H. Audrain, K. Bhate, S. J. Brown, S. Baryschpolec, S. Darne, A. Durack, V. Dvorakova, J. GachN. Goldstraw, H. Goodyear, S. Grabczynska, D. Greenblatt, J. Halpern, R. M.R. Hearn, S. Hoey, B. Hughes, R. Jayaraj, E. K. Johansson, M. Lam, S. Leech, G. M. O'Regan, D. Morrison, W. Porter, R. Ramesh, T. Schill, L. Shaw, A. E.M. Taylor, R. Taylor, J. Thomson, P. Tiffin, M. Tsakok, S. R. Janmohamed, B. Laguda, T. McPherson, A. P. Oranje, A. Patrizi, J. C. Ravenscroft, Carsten Flohr*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Propranolol in the treatment of infantile haemangiomas: Lessons from the European Propranolol in the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science